| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |